Navigation Links
Pharmaceutical Execs to Gain Manufacturing Insights from Top Aerospace, Automotive and Other Non-Pharma Industries at Unique ISPE Event

TAMPA, Fla., Jan. 31, 2013 /PRNewswire-USNewswire/ -- ISPE announced today that it will bring together top executives from the aerospace, automotive and other non-pharmaceutical industries to share manufacturing and quality innovations in an Executive Forum in Philadelphia, Penn. USA, 2-3 April 2013. Attendees will receive a rare opportunity to convene with world-class leaders and to gain industry-advancing insight related to lifecycle development and management, best manufacturing practices, continuous manufacturing, supplier development, quality management systems and leadership.


"ISPE is dedicated to leading the pharmaceutical industry by addressing significant issues that have the greatest potential to enhance manufacturing and production, quality, engineering and regulatory matters throughout the product lifecycle. Through this all-new event, ISPE will facilitate executive-level discussions that go beyond best practices in the pharmaceutical industry, featuring presentations from other industries facing similar manufacturing, quality and global integration challenges," said Nancy Berg , ISPE President and CEO. "The discussions planned for this conference will help Members, pharmaceutical companies and their suppliers translate solutions and lessons learned from other industries into their own operations."

Notable speakers at this conference include:

  • Janet Woodcock , Director, Center for Drug Evaluation and Research (CDER), FDA, USA
  • Craig Kennedy , Senior Vice President, Supply Chain Management, Merck Manufacturing Division, Merck & Co. Inc., USA
  • Philip Dunford , Vice President, General Manager, Boeing Military Aircraft, The Boeing Company, USA
  • Ken Shead , Vice President of Quality and Manufacturing, The Boeing Company, USA
  • Jerry Bussell , Author of "Anatomy of a Lean Leader ", President, Bussell Lean Associates, retired Vice President of Operational Excellence, Medtronic Surgical Technologies

Pharma industry executives leading this event serving as moderators include:

  • Mary Oates , Vice President Global Quality, Pfizer
  • Andy Skibo , Executive Vice President, Operations, MedImmune
  • Joe Famulare , Senior Director, Global Compliance & External Collaboration, Genentech
  • Andy Signore , President and Founder, Institute for Strategic Growth.

More information on the 2013 ISPE Executive Forum, including complete education details and registration information is available at

About ISPE
ISPE, the International Society for Pharmaceutical Engineering, is the world's largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the entire pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA and offices in Brussels, Belgium, Singapore and Shanghai, China. Visit for more information.

For more information contact:
Danielle Hould
ISPE Communications Manager

Tel: +1-813-960-2105, ext. 277

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
4. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
5. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
6. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
7. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
8. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
9. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
10. Icahn Issues Statement Regarding Amylin Pharmaceuticals
11. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
Post Your Comments:
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: DHRM ) ... medical devices and wearable sleep respiratory products in ... with Hongyuan Supply Chain Management Co., Ltd. (hereinafter referred ... to develop Dehaier,s new Internet medical technology business. ... Hongyuan Supply Chain,s sales platform to reach Dehaier,s dealers ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
Breaking Medicine News(10 mins):